• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 649

Substance: β-galactosidase enzyme preparation from Bacillus circulans produced in Bacillus subtilis
Intended Use: For use as a processing aid in the production of galacto-oligosaccharides (GOS).
Basis: Scientific procedures
Notifier: GenoFocus, Inc.
65, Techno 1-ro, Yuseong-gu, Daejeon, Korea, 34014
Date of filing: May 25, 2016
GRAS Notice (releasable information): 649 (in PDF) (6.2 MB)
Date of closure / FDA's Letter: Nov 28, 2016
FDA has no questions
-
-